Nakanoshima Qross Health Accelerator Program (NQHA)is part of the NQ Global Startup Gateway (Nakanoshima Cross Global Startup Creation and Base Promotion Project) sponsored by the Osaka Prefectural Government, a program focused on creating startups that will be active globally through the provision of tailor-made startup support programs and overseas travel support programs. AstraZeneca, Cambridge Consultants, and Medtec Actuator have collaborated to create this program, which focuses on overseas market development through the provision of tailor-made startup support programs and overseas travel support programs.
As an open session of the NQHA, a special panel discussion will be held on strategic positioning for medical and healthcare startups aiming for the UK market.
We will delve into the UK regulatory system, working with the NHS (National Health Service), investment and funding avenues, and real-life commercialization lessons learned in the field, with insights from leaders with real-world experience.
Outline of the event
Date and time:Wednesday, January 28, 2026, 16:00-18:00(including networking)
Location:Nakanoshima Qross 2F Qrossover Lounge Yume(4-3-51 Nakanoshima, Kita-ku, Osaka City)
Who is eligible to participate:Those involved in medical/healthcare startups and their support
Language:English (language) Interpretation is not available.
Participation Fee:free
For inquiries, please contact
info@miracle-science-innovation.jp
NQ Global Startup Gateway Joint Venture
Representative Organization MIRACLE SCIENCE INNOVATION Co.
Attn: YOSHIDA Misato